摘要
<正>癌症以其较高的死亡率得到全世界的关注~([1])。来自癌症基因组项目的新证据表明,大多数恶性肿瘤具有显著的异质性,因此降低了利用基因缺陷进行治疗的有效性~([2])。肿瘤细胞的增殖主要依靠葡萄糖酵解来快速提供能量,这种现象称为Warburg效应~([3-7])。生酮饮食(KD)是通过限制碳水化合物来限制癌细胞的能量来源,依靠在线粒体中的脂肪酸氧化为健康细胞提供能
引文
[1]Siegel RL,Miller KD,Jemal A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
[2]Nik-Zainal S,Davies H,Staaf J,et al.Landscape of somatic mutations in 560 breast cancer whole-genome sequences[J].Nature,2016,534(7605):47-54.
[3]Pacini N,Borziani F.Oncostatic-cytoprotective effect of melatonin and other bioactive molecules:a common target in mitochondrial respiration[J].Int J Mol Sci,2016,17(3):341.DOI:10.3390/ijms17030341.
[4]Schroeder U,Himpe B,Pries R,et al.Decline of lactate in tumor tissue after ketogenic diet:in vivo microdialysis study in patients with head and neck cancer[J].Nutr Cancer,2013,65(6):843-849.
[5]Hainaut P,Plymoth A.Cancer as a metabolic disease[J].Curr Opin Oncol,2012,24(1):56-57.
[6]Warburg O,Wind F,Negelein E.The metabolism of tumors in the body[J].J Gen Physiol,1927,8(6):519-530.
[7]Hao GW,Chen YS,He DM,et al.Growth of human colon cancer cells in nude mice is delayed by ketogenic diet with or without omega-3fatty acids and medium-chain triglycerides[J].Asian Pac J Cancer Prev,2015,16(5):2061-2068.
[8]Seyfried TN,Flores RE,Poff AM,et al.Cancer as a metabolic disease:implications for novel therapeutics[J].Carcinogenesis,2014,35(3):515-527.
[9]Poff AM,Ari C,Seyfried TN,et al.The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer[J].PLo S One,2013,8(6):e65522.DOI:10.1371/journal.pone.0065522.
[10]Allen BG,Bhatia SK,Buatti JM,et al.Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts[J].Clin Cancer Res,2013,19(14):3905-3913.
[11]Streijger F,Plunet WT,Lee JH,et al.Ketogenic diet improves forelimb motor function after spinal cord injury in rodents[J].PLo S One,2013,8(11):e78765.DOI:10.1371/journal.pone.0078765.
[12]Zhang J,Jia PP,Liu QL,et al.Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo[J].J Lipid Res,2018,59(4):625-634.
[13]Freeman JM,Kossoff EH.Ketosis and the ketogenic diet,2010:advances in treating epilepsy and other disorders[J].Adv Pediatr,2010,57(1):315-329.
[14]Newman JC,Verdin E.Ketone bodies as signaling metabolites[J].Trends Endocrinol Metab,2014,25(1):42-52.
[15]Schwartz KA,Noel M,Nikolai M,et al.Investigating the ketogenic diet as treatment for primary aggressive brain cancer:challenges and lessons learned[J].Front Nutr,2018,5:11.DOI:10.3389/fnut.2018.00011.
[16]Schwartz K,Chang HT,Nikolai M,et al.Treatment of glioma patients with ketogenic diets:report of two cases treated with an IRBapproved energy-restricted ketogenic diet protocol and review of the literature[J].Cancer Metab,2015,3:3.DOI:10.1186/s40170-015-0129-1.
[17]Klement RJ.Beneficial effects of ketogenic diets for cancer patients:a realist review with focus on evidence and confirmation[J].Med Oncol,2017,34(8):132.DOI:10.1007/s12032-017-0991-5.
[18]Gullett NP,Mazurak VC,Hebbar G,et al.Nutritional interventions for cancer-induced cachexia[J].Curr Probl Cancer,2011,35(2):58-90.
[19]Seo JH,Lee YM,Lee JS,et al.Efficacy and tolerability of the ketogenic diet according to lipid:nonlipid ratios-comparison of 3:1with 4:1 diet[J].Epilepsia,2007,48(4):801-805.
[20]Freedland SJ,Mavropoulos J,Wang A,et al.Carbohydrate restriction,prostate cancer growth,and the insulin-like growth factor axis[J].Prostate,2008,68(1):11-19.
[21]Sch觟nfeld P,Wojtczak L.Short-and medium-chain fatty acids in energy metabolism:the cellular perspective[J].J Lipid Res,2016,57(6):943-954.
[22]Strowd RE,Grossman SA.The role of glucose modulation and dietary supplementation in patients with central nervous system tumors[J].Curr Treat Options Oncol,2015,16(8):36.DOI:10.1007/s11864-015-0356-2.
[23]Morscher RJ,Aminzadeh-Gohari S,Hauser-Kronberger C,et al.Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model[J].Oncotarget,2016,7(13):17060-17073.
[24]Otto C,Kaemmerer U,Illert B,et al.Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides[J].BMC Cancer,2008,8:122.DOI:10.1186/1471-2407-8-122.
[25]Aminzadeh-Gohari S,Feichtinger RG,Vidali SA,et al.Ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model[J].Oncotarget,2017,8(39):64728-64744.
[26]Paoli A,Moro T,Bosco G,et al.Effects of n-3 polyunsaturated fatty acids supplementation on some cardiovascular risk factors with a ketogenic mediterranean diet[J].Mar Drugs,2015,13(2):996-1009.
[27]Shukla SK,Gebregiworgis T,Purohit V,et al.Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia[J].Cancer Metab,2014,2:18.DOI:10.1186/2049-3002-2-18.
[28]Lis′kiewicz AD,Kasprowska-Lis′kiewicz D,S覥ugocka A.The modification of the ketogenic diet mitigates its stunting effects in rodents[J].Appl Physiol Nutr Metab,2018,43(2):203-210.
[29]Tan-Shalaby JL,Carrick J,Edinger K,et al.Modified Atkins diet in advanced malignancies-final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System[J].Nutr Metab,2016,13(1):61.DOI:10.1186/s12986-016-0120-z.
[30]Cavaleri F,Bashar E.Potential synergies ofβ-hydroxybutyrate and butyrate on the modulation of metabolism,inflammation,cognition,and general health[J].J Nutr Metab,2018:1-13.DOI:10.1155/2018/7195760.
[31]Brown JC,Harhay MO,Harhay MN.Patient-reported versus objectively-measured physical function and mortality risk among cancer survivors[J].J Geriatr Oncol,2016,7(2):108-115.
[32]Sremanakova J,Sowerbutts AM,Burden S.A systematic review of the use of ketogenic diets in adult patients with cancer[J].J Hum Nutr Diet,2018,31(6):793-802.
[33]Wang XS,Zhao F,Fisch MJ,et al.Prevalence and characteristics of moderate to severe fatigue:a multicenter study in cancer patients and survivors[J].Cancer,2014,120(3):425-432.
[34]Williams LA,Agarwal S,Bodurka DC,et al.Capturing the patient’s experience:using qualitative methods to develop a measure of patient-reported symptom burden:an example from ovarian cancer[J].J Pain Symptom Manage,2013,46(6):837-845.
[35]Ebede CC,Jang Y,Escalante CP.Cancer-related fatigue in cancer survivorship[J].Med Clin North Am,2017,101(6):1085-1097.
[36]Breymeyer KL,Lampe JW,Mc Gregor BA,et al.Subjective mood and energy levels of healthy weight and overweight/obese healthy adults on high-and low-glycemic load experimental diets[J].Appetite,2016,107:253-259.DOI:10.1016/j.appet.2016.08.008.
[37]Gibson AA,Seimon RV,Lee CM,et al.Do ketogenic diets really suppress appetite?a systematic review and meta-analysis[J].Obes Rev,2015,16(1):64-76.
[38]Caroline WC,Kevin RF,Rebecca CA,et al.Favorable effects of a ketogenic diet on physical function,perceived energy,and food cravings in women with ovarian or endometrial cancer:a randomized,controlled trial[J].Nutrients,2018,10(9):E1187.DOI:10.3390/nu10091187.
[39]Zhou S,Kachhap S,Sun W,et al.Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck[J].Proc Natl Acad Sci U S A,2007,104(18):7540-7545.
[40]Wallace DC,Fan W.The pathophysiology of mitochondrial disease as modeled in the mouse[J].Genes Dev,2009,23(15):1714-1736.
[41]Aykin-Burns N,Ahmad IM,Zhu Y,et al.Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation[J].Biochem J,2009,418(1):29-37.
[42]Wen S,Zhu D,Huang P.Targeting cancer cell mitochondria as a therapeutic approach[J].Future Med Chem,2013,5(1):53-67.
[43]Fruehauf JP,Meyskens FL.Reactive oxygen species:a breath of life or death[J].Clin Cancer Res,2007,13(3):789-794.
[44]Allen BG,Bhatia SK,Anderson CM,et al.Ketogenic diets as an adjuvant cancer therapy:history and potential mechanism[J].Redox Biol,2014,2:963-970.DOI:10.1016/j.redox.2014.08.002.
[45]Vincent JM,Frederick AV,Jeff S.Nutritional ketosis and mitohormesis:potential implications for mitochondrial function and human health[J].J Nutr Metab,2018:1-27.DOI:10.1155/2018/5157645.
[46]Attardi G,Schatz G.Biogenesis of mitochondria[J].Annu Rev Cell Biol,1988,4:289-333.DOI:10.1146/annurev.cb.04.110188.001445.
[47]Milder JB,Patel M.Modulation of oxidative stress and mitochondrial function by the ketogenic diet[J].Epilepsy Res,2012,100(3):295-303.
[48]Jain SK,Kannan K,Lim G.Ketosis(acetoacetate)can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells[J].Free Radic Biol Med,1998,25(9):1083-1088.
[49]Abdelmegeed MA,Kim SK,Woodcroft KJ,et al.Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes:role of oxidative stress[J].J Pharmacol Exp Ther,2004,310(2):728-736.
[50]Pelletier A,Coderre L.Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes[J].Am J Physiol Endocrinol Metab,2007,292(5):E1325-E1332.
[51]Poff AM,Ward N,Seyfried TN,et al.Non-toxic metabolic management of metastatic cancer in VM mice:novel combination of ketogenic diet,ketone supplementation,and hyperbaric xxygen therapy[J].PLo S One,2015,10(6):e0127407.DOI:10.1371/journal.pone.0127407.
[52]Engelman JA.Targeting PI3K signalling in cancer:opportunities,challenges and limitations[J].Nat Rev Cancer,2009,9(8):550-562.
[53]Klement RJ,Kammerer U.Is there a role for carbohydrate restriction in the treatment and prevention of cancer[J].Nutr Metab(Lond),2011,8:75.DOI:10.1186/1743-7075-8-75.
[54]De Berardinis RJ,Lum JJ,Hatzivassiliou G,et al.The biology of cancer:metabolic reprogramming fuels cell growth and proliferation[J].Cell Metab,2008,7(1):11-20.
[55]Branco AF,Ferreira A,Sim觛es RF,et al.Ketogenic diets:from cancer to mitochondrial diseases and beyond[J].Eur J Clin Invest,2016,46(3):285-298.
[56]Makinoshima H,Takita M,Saruwatari K,et al.Signaling through the phosphatidylinositol 3-kinase(PI3K)/mammalian target of rapamycin(m TOR)axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor(EGFR)-mutated lung adenocarcinoma[J].J Biol Chem,2015,290(28):17495-17504.
[57]Parajuli P,Tiwari RV,Sylvester PW.Anticancer effects of gammatocotrienol are associated with a suppression in aerobic glycolysis[J].Biol Pharm Bull,2015,38(9):1352-1360.
[58]Schlaepfer IR,Rider L,Rodrigues LU,et al.Lipid catabolism via CPT1 as a therapeutic target for prostate cancer[J].Mol Cancer Ther,2014,13(10):2361-2371.
[59]Meidenbauer JJ,Mukherjee P,Seyfried TN.The glucose ketone index calculator:a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer[J].Nutr Metab(Lond),2015,12:12.DOI:10.1186/s12986-015-0009-2.
[60]Fine EJ,Segal-Isaacson CJ,Feinman RD,et al.Targeting insulin inhibition as a metabolic therapy in advanced cancer:a pilot safety and feasibility dietary trial in 10 patients[J].Nutrition,2012,28(10):1028-1035.
[61]Fine E,Segal-Isaacson C,Feinman R,et al.Carbohydrate restriction in patients with advanced cancer:a protocol to assess safety and feasibility with an accompanying hypothesis[J].Community Oncology,2008,5(1):22-26.
[62]Fine EJ,Miller A,Quadros EV,et al.Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2[J].Cancer Cell Int,2009,9:14.DOI:10.1186/1475-2867-9-14.
[63]Beck SA,Tisdale MJ.Effect of insulin on weight loss and tumour growth in a cachexia model[J].Br J Cancer,1989,59(5):677-681.
[64]Gunter MJ,Hoover DR,Yu H,et al.Insulin,insulin-like growth factor-I,and risk of breast cancer in postmenopausal women[J].J Natl Cancer Inst,2009,101(1):48-60.
[65]Gunter MJ,Hoover DR,Yu H,et al.Insulin,insulin-like growth factor-I,endogenous estradiol,and risk of colorectal cancer in postmenopausal women.[J].Cancer Res,2008,68(1):329-337.
[66]Wang Q,Zhou Y,Rychahou P,et al.Ketogenesis contributes to intestinal cell differentiation[J].Cell Death Differ,2017,24(3):458-468.
[67]Hammoud SS,Cairns BR,Jones DA.Epigenetic regulation of colon cancer and intestinal stem cells[J].Curr Opin Cell Biol,2013,25(2):177-183.
[68]Zhou Y,Rychahou P,Wang Q,et al.TSC2/m TORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium[J].Cell Death Dis,2015,6:e1631.DOI:10.1038/cddis.2014.588.
[69]Kmiecik J,Poli A,Brons NH,et al.Elevated CD3+and CD8+tumorinfiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level[J].J Neuroimmunol,2013,264(1-2):71-83.
[70]Wing K,Sakaguchi S.Regulatory T cells exert checks and balances on self tolerance and autoimmunity[J].Nat Immunol,2010,11(1):7-13.
[71]Fecci PE,Mitchell DA,Whitesides JF,et al.Increased regulatory Tcell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma[J].Cancer Res,2006,66(6):3294-3302.
[72]Husain Z,Huang Y,Seth P,et al.Tumor-derived lactate modifies antitumor immune response:effect on myeloid-derived suppressor cells and NK cells[J].J Immunol,2013,191(3):1486-1495.
[73]Molon B,Cali B,Viola A.T cells and cancer:how metabolism shapes immunity[J].Front Immunol,2016,7:20.DOI:10.3389/fimmu.2016.00020.
[74]Lussier DM,Woolf EC,Johnson JL,et al.Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet[J].BMC Cancer,2016,16:310.DOI:10.1186/s12885-016-2337-7.
[75]Ampie L,Woolf EC,Dardis C.Immunotherapeutic advancements for glioblastoma[J].Front Oncol,2015,5:12.DOI:10.3389/fonc.2015.00012.
[76]Nduom EK,Weller M,Heimberger AB.Immunosuppressive mechanisms in glioblastoma[J].Neuro Oncol,2015,17(7):vii9-vii14.DOI:10.1093/neuonc/nov151.
[77]Sukumar M,Roychoudhuri R,Restifo NP.Nutrient competition:a new axis of tumor immunosuppression[J].Cell,2015,162(6):1206-1208.
[78]Palaiologos G,Felig P.Effects of ketone bodies on amino acid metabolism in isolated rat diaphragm[J].Biochem J,1976,154(3):709-716.
[79]Klement RJ,Frobel T,Albers T,et al.A pilot case study on the impact of a self-prescribed ketogenic diet on biochemical parameters and running performance in healthy and physically active individuals[J].Nutr Med,2013,1(1):10-37.
[80]Nakamura K,Tonouchi H,Sasayama A,et al.A ketogenic formula prevents tumor progression and cancer cachexia by attenuating systemic inflammation in colon 26 tumor-bearing mice[J].Nutrients,2018,10(2):pii:E206.DOI:10.3390/nu10020206.
[81]Breitkreutz R,Tesdal K,Jentschura D,et al.Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy:a randomized controlled study[J].Wien Klin Wochenschr,2005,117(19-20):685-692.
[82]Nebeling LC,Miraldi F,Shurin SB,et al.Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients:two case reports[J].J Am Coll Nutr,1995,14(2):202-208.
[83]Dhamija R,Eckert S,Wirrell E.Ketogenic diet[J].Can J Neurol Sci,2013,40(2):158-167.
[84]Nangia S,Caraballo RH,Kang HC,et al.Is the ketogenic diet effective in specific epilepsy syndromes[J].Epilepsy Res,2012,100(3):252-257.
[85]Mosek A,Natour H,Neufeld MY,et al.Ketogenic diet treatment in adults with refractory epilepsy:a prospective pilot study[J].Seizure,2009,18(1):30-33.
[86]Hayashi A,Kumada T,Nozaki F,et al.Changes in serum levels of selenium,zinc and copper in patients on a ketogenic diet using ketonformula[J].No To Hattatsu,2013,45(4):288-293.
[87]Westerterp-Plantenga MS,Nieuwenhuizen A,ToméD,et al.Dietary protein,weight loss,and weight maintenance[J].Annu Rev Nutr,2009,29(1):21-41.
[88]Moriyama K,Watanabe M,Yamada Y,et al.Protein-losing enteropathy as a rare complication of the ketogenic diet[J].Pediatr Neurol,2015,52(5):526-528.
[89]Hawkes CP,Levine MA.Ketotic hypercalcemia:a case series and description of a novel entity[J].J Clin Endocrinol Metab,2014,99(5):1531-1536.
[90]Weber DD,Aminazdeh-Gohari S,Kofler B.Ketogenic diet in cancer therapy[J].Aging(Albany NY),2018,10(2):164-165.
[91]Lis′kiewicz AD,Kasprowska D,Wojakowska A,et al.Long-term high fat ketogenic diet promotes renal tumor growth in a rat model of tuberous sclerosis[J].Sci Rep,2016,6:21807.DOI:10.1038/srep21807.
[92]Xia S,Lin R,Jin L,et al.Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth[J].Cell Metab,2017,25(2):358-373.
